{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:17:05Z","timestamp":1768447025669,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T00:00:00Z","timestamp":1407456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Service of Infectious Diseases, Lausanne University Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2014,11]]},"abstract":"Objectives<\/jats:title>K<\/jats:styled-content>aposi's sarcoma (KS<\/jats:styled-content>), invasive cervical carcinoma (ICC<\/jats:styled-content>) and non\u2010H<\/jats:styled-content>odgkin lymphoma (NHL<\/jats:styled-content>) have been listed as AIDS<\/jats:styled-content>\u2010defining cancers (ADCs<\/jats:styled-content>) by the Centers for Disease Control and Prevention since 1993. Despite this, HIV<\/jats:styled-content> screening is not universally mentioned in ADC<\/jats:styled-content> treatment guidelines. We examined screening practices at a tertiary centre serving a population where HIV<\/jats:styled-content> seroprevalence is 0.4%.<\/jats:p><\/jats:sec>Methods<\/jats:title>Patients with KS<\/jats:styled-content>, ICC<\/jats:styled-content>, NHL<\/jats:styled-content> and H<\/jats:styled-content>odgkin lymphoma (HL<\/jats:styled-content>), treated at L<\/jats:styled-content>ausanne U<\/jats:styled-content>niversity H<\/jats:styled-content>ospital between J<\/jats:styled-content>anuary 2002 and J<\/jats:styled-content>uly 2012, were studied retrospectively. HIV<\/jats:styled-content> testing was considered part of the oncology work\u2010up if performed between 90 days before and 90 days after the cancer diagnosis date.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 880 patients were examined: 10 with KS<\/jats:styled-content>, 58 with ICC<\/jats:styled-content>, 672 with NHL<\/jats:styled-content> and 140 with HL<\/jats:styled-content>. HIV<\/jats:styled-content> testing rates were 100, 11, 60 and 59%, and HIV<\/jats:styled-content> seroprevalence was 60, 1.7, 3.4 and 5%, respectively. Thirty\u2010seven patients (4.2%) were HIV<\/jats:styled-content>\u2010positive, of whom eight (22%) were diagnosed at oncology work\u2010up. All newly diagnosed patients had CD4<\/jats:styled-content> counts <\u2009200 cells\/\u03bcL and six (75%) had presented to a physician 12\u2013236 weeks previously with conditions warranting HIV<\/jats:styled-content> testing.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>In our institution, only patients with KS<\/jats:styled-content> were universally screened. Screening rates for other cancers ranged from 11 to 60%. HIV<\/jats:styled-content> seroprevalence was at least fourfold higher than the population average. As HIV<\/jats:styled-content>\u2010positive status impacts on cancer patient medical management, HIV<\/jats:styled-content> screening should be included in oncology guidelines. Further, we recommend that opt\u2010out screening should be adopted in all patients with ADCs<\/jats:styled-content> and HL<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12181","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T11:54:41Z","timestamp":1407498881000},"page":"631-634","source":"Crossref","is-referenced-by-count":17,"title":["Patients with AIDS<\/scp>\u2010defining cancers are not universally screened for HIV<\/scp>: a 10\u2010year retrospective analysis of HIV<\/scp>\u2010testing practices in a S<\/scp>wiss university hospital"],"prefix":"10.1111","volume":"15","author":[{"given":"V","family":"Mosimann","sequence":"first","affiliation":[{"name":"Faculty of Biology and Medicine University of Lausanne Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Cavassini","sequence":"additional","affiliation":[{"name":"Service of Infectious Diseases Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Hugli","sequence":"additional","affiliation":[{"name":"Emergency Department Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mamin","sequence":"additional","affiliation":[{"name":"Service of Immunology and Allergy Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Achtari","sequence":"additional","affiliation":[{"name":"Service of Gynaecology Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Oncology Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEA","family":"Darling","sequence":"additional","affiliation":[{"name":"Service of Infectious Diseases Lausanne University Hospital Lausanne Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"issue":"17","key":"e_1_2_7_2_1","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds273"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds268"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e318287d329"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr378"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3283560697"},{"key":"e_1_2_7_8_1","first-page":"704","article-title":"The prognosis of HIV\u2010infected patients with diffuse large B\u2010cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV\u2010negative patients receiving chemotherapy","volume":"90","author":"Navarro JT","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.41.4193"},{"issue":"14","key":"e_1_2_7_10_1","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health\u2010care settings","volume":"55","author":"Branson BM","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.9-5-471"},{"key":"e_1_2_7_12_1","unstructured":"UNAIDS epidemiology figures 2009.2009. Switzerland. Available athttp:\/\/www.unaids.org\/en\/regionscountries\/countries\/switzerland\/. (accessed 5 February 2014)."},{"key":"e_1_2_7_13_1","unstructured":"Office f\u00e9d\u00e9ral de la sant\u00e9 publique.D\u00e9pistage du VIH et conseil initi\u00e9s par les m\u00e9decins. Bulletin2007. 371\u20133. Available athttp:\/\/www.bag.admin.ch\/hiv_aids\/12472\/12474\/?lang=fr. (accessed 5 February 2014)."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039299"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyp321"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052845"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833c7b9c"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00566.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2012.00993.x"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12181","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12181","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.12181","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T03:01:03Z","timestamp":1696302063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,8]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.1111\/hiv.12181"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12181","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,8]]}}}